Biologics Modular was started in early 2010 to reduce cost and time of biotechnology and pharmaceutical drug manufacturing and development processes. Historically, companies in this industry have dedicated significant time and capital to either building out large-scale manufacturing facilities according to strict FDA guidelines or spending significant capital outsourcing their drug manufacturing to certified partners. With the industry moving towards personalized drugs, small batch and single use technologies offer biotechnology and pharmaceutical companies new alternatives to how they have traditionally manufactured products. Biologics Modular's facilities empower their customers to embrace alternative approaches.
Biologics Modular's pre-constructed, pre-validated, transportable facilities allow both large and small biotech companies the flexibility and cost-savings needed to test new products or scale up and scale down the production of smaller batch drugs to adapt to the changing needs of their customers. Biologics Modular's facilities can be configured to support as much flexibility in production as is required by the customer. Drug manufacturers can use Biologics Modular's facilities (which are constructed in shipping container structures) to ramp up a production ready facility in as little as 6 months. Timeline for a traditional facility buildout and validation typically 2 years. This approach has been recognized by industry authorities as an ideal template for future drug manufacturing. The Compay's platform can also be used in markets other than drug development, most notably for hospitals and compounding pharmacies where certain facilitates are now required to meet FDA-level standards.
Biologics Modular has raised over $2 MM in capital and spent nearly 3 years developing its modular facilities, getting input from the FDA and creating meaningful partnerships with equipment manufacturers. Biologics Modular's current prospective customer interest is growing and the Company is looking to ramp up its sales and marketing efforts in order to increase brand awareness and grow its customer pipeline.
Financial Summary
Previous Fundraise Summary
| Security Type | Equity | |
|---|---|---|
| Investor Eligibility | All Investors |
Offering Materials
There are no offering materials available for this business. Check back soon.
Learn about investing in preferred equity
Financials
Q&A
Team
Clark H Byrum Jr.
CEO / President
Clark has over 15 years of leadership and management experience in bank management and investment banking. Most recently Clark oversaw investment and trust operations and institutional investments at American State Bank and advised in transactions at Ross Sinclaire & Associates. Clark holds a B.S. from Kelley School of Business at Indiana University.
Mike Katsis
VP Business Development
Mike leads the sales and business development efforts at Biologics Modular, Mike is focusing on relationship building and customer education. He has ove 25 years of extensive experience in sales, management and Buisness Development. Prior to joining Biologics Modular, Mike has held various senior level positions: Biologics Modular, LLC, Jada Beauty,The Sandstone Group, Inc.,Qtrac Software, LLC.,The Stratford Companies, Inc. and Sun Industries, Inc.
Chris Wernimont
VP Engineering
Chris is responsible for the development and implementation of design, procurement, supply chain management, and project management of all phases of customer requirement definition, design solution, material and component purchase, installation, performance testing and validation to FDA requirements. Chris holds a BS degree and MS degree in Chemical Engineering from the Rose-Hulman Institute of Technology. He began his career with Eli Lilly and Company and held various engineering, GMP manufacturing management and capital project management positions while employed there. He has more than 25 years of experience in the industry and has helped successfully deliver on over $800 MM worth of biopharmaceutical capital projects.
Charles A. Hall
VP Finance
Charles leads accounting and financial management and reporting functions at Biologics Modular. He has over 30 years of experience in accounting and financial management most recently at the Key Corporation. Other experience includes Key Life Insurance Company and The Statesman Group. Currently, Charles also serves as Treasure at the Key Corporation. He holds a B.S. in accounting from Indiana University.
Matt Macaluso
Legal Counsel
Matt provides legal counsel to Biologics Modular. He is a founder of Keller Macaluso where he leads entrepreneurial and business services groups. He advises on transactional and contract matters for sports and motorsports business and closely held entrepreneurial and emerging growth companies. Matt holds a juris doctorate, cum laude, from the Valparaiso University Law School and a B.S. from the Krannert School of Management at Purdue University.
About Biologics Modular
Company Updates
Interphex Tradeshow Update
March 22, 2014
Biologics Modular was featured at the Interphex Show on the IPS tour http://digital.pharmpro.com/pharmaceuticalprodu...
The expanding popularity of the Biologics Modular Deploy Ready Platform is evident with Large Pharmaceutical and Biotech companies. Representatives of Biologics Modular met with several A/E firms and large manufacturers to begin the review of slated new facilities.
Biologics Modular Now Open for Funding
March 10, 2014
Biologics Modular is excited to announce that it has secured initial investment and is now available for additional funding on Localstake. Login to Localstake to view Company materials and complete investment. The Biologics team is looking forward to continuing its initial momentum towards its target funding goal. Feel free to reach out to Localstake or Clark Byrum, President / CEO of Biologics (cbyrum@biologicsmodular.com) with any questions.
Clark and Biologics Modular were featured on a recent edition of Inside Indiana Business with Gerry Dick. Click the below link for video.
Discussion
| Topic | Last activity |
|---|---|
| Sales Activity 2 comments | over 4 years ago |
Express Interest
If the business begins fundraising, you will be able to review and complete the investment steps.
Expressing Interest FAQ
Expressing interest covers a few different functions. First, it acts as your indication to the business that you have a potential interest in considering an investment. It is also the means by which you are able to access additional materials from the business. The reason you must express interest to view this information is so that the business can keep track of who has accessed their sometimes confidential information. Lastly, expressing interest allows you to keep in touch and stay updated on the progress of the business as they work through their fundraise.
An expression of interest is non-binding. Providing a dollar amount of interest to the business is exclusively a way for them to get a better understanding of whether there is sufficient aggregate interest from investors to support their fundraise goals. If you do not provide a dollar amount to the business, this is fine, but they may decide to cancel their fundraise if they do not have a clear enough picture as to whether there is enough interest to meet their goals.
Yes. Interest can be cancelled at any time, and after cancelling the business will have no means by which to contact you. If you cancel your interest, you can always express interest again if you change your mind.
Yes. The business will be able to contact you through Localstake Marketplace platform messaging. They will not receive any other personal contact information (i.e. email address, phone number, etc.).
When you express interest in a business, they will receive a notification that you are interested. On their investor management interface, they will see your name, state of residence, occupation, and amount of investment.
Company Updates
Interphex Tradeshow Update
March 22, 2014
Biologics Modular was featured at the Interphex Show on the IPS tour http://digital.pharmpro.com/pharmaceuticalprodu...
The expanding popularity of the Biologics Modular Deploy Ready Platform is evident with Large Pharmaceutical and Biotech companies. Representatives of Biologics Modular met with several A/E firms and large manufacturers to begin the review of slated new facilities.
Biologics Modular Now Open for Funding
March 10, 2014
Biologics Modular is excited to announce that it has secured initial investment and is now available for additional funding on Localstake. Login to Localstake to view Company materials and complete investment. The Biologics team is looking forward to continuing its initial momentum towards its target funding goal. Feel free to reach out to Localstake or Clark Byrum, President / CEO of Biologics (cbyrum@biologicsmodular.com) with any questions.
Clark and Biologics Modular were featured on a recent edition of Inside Indiana Business with Gerry Dick. Click the below link for video.
Discussion
| Topic | Last activity |
|---|---|
| Sales Activity 2 comments | over 4 years ago |